Search results

{{Short description|Category of drugs used to classify a drug according to certain criteria}} ...on]] (i.e. binding to the same [[biological target]]), a related [[mode of action]], and/or are used to treat the same disease. ...

{{Short description|Category of drugs used to classify a drug according to certain criteria}} ...on]] (i.e. binding to the same [[biological target]]), a related [[mode of action]], and/or are used to treat the same disease. ...

...iological target/ja|生物学的標的]]に結合する）を持ち、関連した[[mode of action/ja|作用機序(mode of action)]]を持ち、および/または同じ疾患の治療に用いられる[[medication/ja|医薬品]]およびその他の化合物の集合である。 薬物クラス一覧: [https://www.drugs.com/drug-classes.html] ...

| ImageName = Skeletal formula of biguanide | ImageName1 = Ball and stick model of biguanide ...

| ImageName = Skeletal formula of biguanide | ImageName1 = Ball and stick model of biguanide ...

| Drugs.com = {{drugs.com|monograph|omega-3-acid-ethyl-esters}} | routes_of_administration = [[By mouth/ja]] ...

...recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. ...-based]] guideline most recently updated in 2018 by the [[American College of Cardiology]] & [[American Heart Association]]. ...

...recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. ...-based]] guideline most recently updated in 2018 by the [[American College of Cardiology]] & [[American Heart Association]]. ...

| Drugs.com = {{drugs.com|monograph|glimepiride}} | routes_of_administration = [[Oral administration|By mouth]] ...

| Drugs.com = {{drugs.com|monograph|glimepiride}} | routes_of_administration = [[Oral administration|By mouth]] ...

{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} ...actions of the endogenous [[incretin]] hormone [[GLP-1]] that is released by the gut after eating. ...

{{Short description|Class of organic compounds used in medicine and agriculture}} ...eneral structural formula of a sulfonylurea. The functional group consists of a sulfonyl group and a N-substituted ureylene group]] ...

{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} ...actions of the endogenous [[incretin]] hormone [[GLP-1]] that is released by the gut after eating. ...

| Drugs.com = {{drugs.com|monograph|telmisartan}} | routes_of_administration = [[Oral administration|By mouth]] ...

{{Short description|Class of organic compounds used in medicine and agriculture}} ...eneral structural formula of a sulfonylurea. The functional group consists of a sulfonyl group and a N-substituted ureylene group]] ...

| Drugs.com = {{drugs.com|monograph|sitagliptin}} | routes_of_administration = [[Oral administration|By mouth]] ...

| Drugs.com = {{drugs.com|monograph|telmisartan}} | routes_of_administration = [[Oral administration|By mouth]] ...

| caption = Chemical structure of [[ethyl eicosapentaenoate]], an important omega-3-acid ethyl ester | Drugs.com = {{drugs.com|monograph|omega-3-acid-ethyl-esters}} ...

| Drugs.com = {{drugs.com|monograph|sitagliptin}} | routes_of_administration = [[Oral administration|By mouth]] ...

| Drugs.com = {{drugs.com|monograph|insulin_glargine}} ...] form of [[insulin (medication)|medical insulin]], used in the management of [[type 1 DM|type I]] and [[type II diabetes]]. It is [[subcutaneous injecti ...